Kala Pharmaceuticals Stock Price. Everything You Need To Know About The Kala Pharmaceuticals Stock!
Kala Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Arlington, Massachusetts, dedicated to the research, development, and commercialization of therapies for rare diseases of the eye. With 34 full-time employees, the company is focused on using its Mesenchymal Stem Cell Secretome (MSC-S) platform to develop biologics-based investigational therapies for rare front-of-the-eye diseases.
Kala Pharmaceuticals’ lead product candidate, KPI-012, is in clinical development for the treatment of persistent corneal epithelial defect (PCED), a rare disease of impaired corneal healing that has received orphan drug designation from the United States Food and Drug Administration. The company is also evaluating the potential development of KPI-012 for additional rare front-of-the-eye diseases, such as Limbal Stem Cell Deficiency and ocular manifestations of moderate-to-severe Sjogren’s.
Additionally, Kala Pharmaceuticals plans to initiate preclinical studies to evaluate the potential utility of its MSC-S platform for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease. By leveraging its MSC-S platform, the company is poised to make a significant impact in the field of rare eye diseases.
Since going public in 2017, Kala Pharmaceuticals has been committed to advancing its pipeline and bringing new treatments to patients with rare eye diseases. However, as with any investment, it’s important to stay informed about the latest developments in the company, including any changes to its stock price, market cap, or other key financial indicators. By staying up-to-date with these factors, investors can make informed decisions about their investments and potentially reap the rewards of a well-performing stock.
Kala Pharmaceuticals Stock Price. Everything You Need To Know About The Kala Pharmaceuticals Stock! performance
- Employees 34
- Company HQ Arlington
- Website https://www.kalarx.com
- KALA Asset Type Common Stock
- KALA Market Capitalization 18.4M
- Earnings Per Share -17.35
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the global stock market? Look no further than Kala Pharmaceuticals, a promising stock that offers great potential for growth. Kala Pharmaceuticals is a cutting-edge biopharmaceutical company focused on developing innovative therapies for eye diseases. With a strong portfolio of novel treatments and a team of experienced researchers, Kala Pharmaceuticals is poised to disrupt the industry and deliver substantial returns to investors. But how can you invest in this lucrative stock from Malaysia, Thailand, Indonesia, or Vietnam? At Zorion, we provide you with the tools and resources you need to make informed investment decisions. Our investment platform allows you to easily invest in real US stocks and Pre-IPO companies like Kala Pharmaceuticals. With our investment insights and recommendations, you can stay ahead of the game and maximize your returns. In addition to our investment platform, we offer a wealth of educational materials and resources to expand your investment knowledge. Whether you’re a seasoned investor or a beginner, our comprehensive guides and expert analysis will help you navigate the complex world of stocks and make smarter investment choices. So why wait? Start investing in Kala Pharmaceuticals and other top stocks with Zorion today. Our user-friendly platform and informative resources are here to empower you on your investment journey. Take charge of your financial future and make the most of your investments with Zorion.
